Premium
TREATMENT OF OCULAR HYPERTENSION WITH ORAL BETA‐ADRENERGIC BLOCKING AGENTS
Author(s) -
PANDOLFI MAURIZIO,
ÖHRSTRÖM ARNE
Publication year - 1974
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1974.tb01757.x
Subject(s) - propranolol , medicine , blocking (statistics) , glaucoma , anesthesia , adrenergic , ophthalmology , adrenergic receptor , ocular hypertension , adrenergic beta antagonists , receptor , statistics , mathematics
Propranolol, a β ‐adrenergic blocking agent, was given by mouth to 22 patients with elevated IOP resistent to conventional medical treatment or where conventional treatment was contraindicated. A lasting reduction of IOP was obtained in 11 cases; open‐angle glaucoma or elevated IOP responded best. No significant side‐effects were observed. Having in mind the contraindications of β ‐adrenergic blocking agents, propranolol can be usefully employed in ophthalmology for controlling elevated IOP.